Transitioning to stage 3 type 1 diabetes: when to start insulin
- PMID: 39208831
- DOI: 10.1016/S2213-8587(24)00238-9
Transitioning to stage 3 type 1 diabetes: when to start insulin
Conflict of interest statement
REJB is funded by the Oxford National Institute for Health and Care Research Biomedical Research Centre, Oxford, UK, through the JDRF/Wellcome Strategic Award (4-SRA-2017-473-A-N; 107212/A/15/Z) and is part of EDENT1FI, which is supported by the Innovative Health Initiative Joint Undertaking under grant agreement 101132379. REJB has been an independent advisor for Provention Bio. She has received speaking honoraria for the EASD Rising stars symposium sponsored by Sanofi and speaking honoraria and travel support for a Medscape educational event; payment for both went into a university educational fund. KJG is an employee of Sanford Health and Sanford Research with grant support from the Helmsley Charitable Trust.. KJG has been a site principal investigator for multicentre clinical trials sponsored by Provention Bio. KJG serves on an advisory board for the North Carolina Early Check Screening Program. KJG has received support from JDRF and The American Diabetes Association to present at meetings.
LinkOut - more resources
Full Text Sources